Annual Revenue
$726.44 M
+$209.20 M+40.45%
December 31, 2023
Summary
- As of February 24, 2025, ACAD annual revenue is $726.44 million, with the most recent change of +$209.20 million (+40.45%) on December 31, 2023.
- During the last 3 years, ACAD annual revenue has risen by +$284.68 million (+64.44%).
- ACAD annual revenue is now at all-time high.
Performance
ACAD Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$250.40 M
+$8.44 M+3.49%
September 30, 2024
Summary
- As of February 24, 2025, ACAD quarterly revenue is $250.40 million, with the most recent change of +$8.44 million (+3.49%) on September 30, 2024.
- Over the past year, ACAD quarterly revenue has increased by +$38.70 million (+18.28%).
- ACAD quarterly revenue is now at all-time high.
Performance
ACAD Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$929.24 M
+$38.70 M+4.35%
September 30, 2024
Summary
- As of February 24, 2025, ACAD TTM revenue is $929.24 million, with the most recent change of +$38.70 million (+4.35%) on September 30, 2024.
- Over the past year, ACAD TTM revenue has increased by +$297.35 million (+47.06%).
- ACAD TTM revenue is now at all-time high.
Performance
ACAD TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ACAD Revenue Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +40.5% | +18.3% | +47.1% |
3 y3 years | +64.4% | +90.3% | +95.9% |
5 y5 years | +224.6% | +164.7% | +174.1% |
ACAD Revenue Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +50.0% | at high | +116.9% | at high | +91.9% |
5 y | 5-year | at high | +114.2% | at high | +178.0% | at high | +174.1% |
alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
ACADIA Pharmaceuticals Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $250.40 M(+3.5%) | $929.24 M(+4.3%) |
Jun 2024 | - | $241.96 M(+17.6%) | $890.53 M(+9.4%) |
Mar 2024 | - | $205.83 M(-10.9%) | $813.81 M(+12.0%) |
Dec 2023 | $726.44 M(+40.4%) | $231.04 M(+9.1%) | $726.44 M(+15.0%) |
Sep 2023 | - | $211.70 M(+28.1%) | $631.89 M(+14.7%) |
Jun 2023 | - | $165.24 M(+39.5%) | $550.90 M(+5.9%) |
Mar 2023 | - | $118.46 M(-13.2%) | $520.23 M(+0.6%) |
Dec 2022 | $517.24 M(+6.8%) | $136.49 M(+4.4%) | $517.24 M(+1.1%) |
Sep 2022 | - | $130.71 M(-2.9%) | $511.50 M(-0.2%) |
Jun 2022 | - | $134.56 M(+16.5%) | $512.40 M(+3.9%) |
Mar 2022 | - | $115.47 M(-11.7%) | $493.06 M(+1.8%) |
Dec 2021 | $484.14 M(+9.6%) | $130.76 M(-0.6%) | $484.14 M(+2.1%) |
Sep 2021 | - | $131.61 M(+14.2%) | $474.39 M(+2.4%) |
Jun 2021 | - | $115.22 M(+8.1%) | $463.36 M(+1.1%) |
Mar 2021 | - | $106.55 M(-11.9%) | $458.24 M(+3.7%) |
Dec 2020 | $441.75 M(+30.3%) | $121.01 M(+0.4%) | $441.75 M(+5.4%) |
Sep 2020 | - | $120.58 M(+9.5%) | $419.07 M(+6.6%) |
Jun 2020 | - | $110.10 M(+22.2%) | $393.08 M(+7.3%) |
Mar 2020 | - | $90.07 M(-8.4%) | $366.19 M(+8.0%) |
Dec 2019 | $339.08 M(+51.5%) | $98.33 M(+4.0%) | $339.08 M(+12.9%) |
Sep 2019 | - | $94.59 M(+13.7%) | $300.32 M(+13.7%) |
Jun 2019 | - | $83.20 M(+32.2%) | $264.04 M(+11.0%) |
Mar 2019 | - | $62.96 M(+5.7%) | $237.90 M(+6.3%) |
Dec 2018 | $223.81 M(+79.2%) | $59.57 M(+2.2%) | $223.81 M(+7.7%) |
Sep 2018 | - | $58.30 M(+2.2%) | $207.80 M(+12.3%) |
Jun 2018 | - | $57.06 M(+16.8%) | $185.07 M(+16.8%) |
Mar 2018 | - | $48.87 M(+12.2%) | $158.48 M(+26.9%) |
Dec 2017 | $124.90 M(+620.7%) | $43.56 M(+22.4%) | $124.90 M(+33.9%) |
Sep 2017 | - | $35.58 M(+16.7%) | $93.30 M(+48.1%) |
Jun 2017 | - | $30.48 M(+99.4%) | $62.99 M(+93.1%) |
Mar 2017 | - | $15.29 M(+27.8%) | $32.61 M(+88.2%) |
Dec 2016 | $17.33 M(>+9900.0%) | $11.96 M(+127.1%) | $17.33 M(+221.8%) |
Sep 2016 | - | $5.27 M(+5330.9%) | $5.39 M(+3330.6%) |
Jun 2016 | - | $97.00 K(+2325.0%) | $157.00 K(+157.4%) |
Mar 2016 | - | $4000.00(-76.5%) | $61.00 K(0.0%) |
Dec 2015 | $61.00 K(-49.2%) | $17.00 K(-56.4%) | $61.00 K(-33.7%) |
Sep 2015 | - | $39.00 K(+3800.0%) | $92.00 K(+35.3%) |
Jun 2015 | - | $1000.00(-75.0%) | $68.00 K(-28.4%) |
Mar 2015 | - | $4000.00(-91.7%) | $95.00 K(-21.5%) |
Dec 2014 | $120.00 K(-89.5%) | $48.00 K(+220.0%) | $121.00 K(+10.0%) |
Sep 2014 | - | $15.00 K(-46.4%) | $110.00 K(-67.2%) |
Jun 2014 | - | $28.00 K(-6.7%) | $335.00 K(-55.8%) |
Mar 2014 | - | $30.00 K(-18.9%) | $758.00 K(-33.8%) |
Dec 2013 | $1.15 M | $37.00 K(-84.6%) | $1.15 M(-23.1%) |
Sep 2013 | - | $240.00 K(-46.8%) | $1.49 M(-68.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2013 | - | $451.00 K(+8.2%) | $4.73 M(-3.0%) |
Mar 2013 | - | $417.00 K(+9.7%) | $4.87 M(-0.7%) |
Dec 2012 | $4.91 M(+137.4%) | $380.00 K(-89.1%) | $4.91 M(-4.1%) |
Sep 2012 | - | $3.48 M(+480.6%) | $5.12 M(+130.3%) |
Jun 2012 | - | $599.00 K(+33.1%) | $2.22 M(+6.7%) |
Mar 2012 | - | $450.00 K(-23.5%) | $2.08 M(+0.7%) |
Dec 2011 | $2.07 M(-95.1%) | $588.00 K(+0.7%) | $2.07 M(-94.4%) |
Sep 2011 | - | $584.00 K(+27.0%) | $36.88 M(-4.4%) |
Jun 2011 | - | $460.00 K(+5.7%) | $38.60 M(-4.5%) |
Mar 2011 | - | $435.00 K(-98.8%) | $40.44 M(-4.0%) |
Dec 2010 | $42.13 M(+558.5%) | $35.40 M(+1438.6%) | $42.13 M(+395.7%) |
Sep 2010 | - | $2.30 M(+0.2%) | $8.50 M(-1.6%) |
Jun 2010 | - | $2.30 M(+7.7%) | $8.63 M(+5.8%) |
Mar 2010 | - | $2.13 M(+20.6%) | $8.16 M(+27.5%) |
Dec 2009 | $6.40 M(+302.5%) | $1.77 M(-27.4%) | $6.40 M(+29.1%) |
Sep 2009 | - | $2.44 M(+33.8%) | $4.95 M(+76.9%) |
Jun 2009 | - | $1.82 M(+386.6%) | $2.80 M(+141.9%) |
Mar 2009 | - | $374.00 K(+15.1%) | $1.16 M(-27.2%) |
Dec 2008 | $1.59 M(-79.0%) | $325.00 K(+15.2%) | $1.59 M(-44.2%) |
Sep 2008 | - | $282.00 K(+59.3%) | $2.85 M(-37.0%) |
Jun 2008 | - | $177.00 K(-78.0%) | $4.52 M(-29.3%) |
Mar 2008 | - | $806.00 K(-49.1%) | $6.40 M(-15.3%) |
Dec 2007 | $7.55 M(-7.1%) | $1.58 M(-19.1%) | $7.55 M(-2.5%) |
Sep 2007 | - | $1.96 M(-4.8%) | $7.75 M(+0.2%) |
Jun 2007 | - | $2.06 M(+4.8%) | $7.73 M(+2.3%) |
Mar 2007 | - | $1.96 M(+10.5%) | $7.56 M(-7.1%) |
Dec 2006 | $8.13 M(-25.8%) | $1.77 M(-8.7%) | $8.13 M(-7.6%) |
Sep 2006 | - | $1.94 M(+3.3%) | $8.80 M(-16.4%) |
Jun 2006 | - | $1.88 M(-25.9%) | $10.53 M(-5.7%) |
Mar 2006 | - | $2.54 M(+3.8%) | $11.17 M(+1.9%) |
Dec 2005 | $10.96 M(+138.0%) | $2.44 M(-33.5%) | $10.96 M(+14.2%) |
Sep 2005 | - | $3.67 M(+46.0%) | $9.60 M(+27.9%) |
Jun 2005 | - | $2.52 M(+8.2%) | $7.50 M(+25.0%) |
Mar 2005 | - | $2.33 M(+114.7%) | $6.01 M(+30.4%) |
Dec 2004 | $4.60 M(-37.6%) | $1.08 M(-31.5%) | $4.60 M(-14.2%) |
Sep 2004 | - | $1.58 M(+55.7%) | $5.37 M(-4.7%) |
Jun 2004 | - | $1.02 M(+9.9%) | $5.63 M(-18.4%) |
Mar 2004 | - | $923.90 K(-49.9%) | $6.89 M(-11.8%) |
Dec 2003 | $7.38 M(+17.6%) | $1.84 M(0.0%) | $7.82 M(+30.9%) |
Sep 2003 | - | $1.84 M(-19.1%) | $5.98 M(+44.7%) |
Jun 2003 | - | $2.28 M(+23.3%) | $4.13 M(+123.3%) |
Mar 2003 | - | $1.85 M | $1.85 M |
Dec 2002 | $6.28 M(+69.0%) | - | - |
Dec 2001 | $3.71 M(-13.9%) | - | - |
Dec 2000 | $4.31 M | - | - |
FAQ
- What is ACADIA Pharmaceuticals annual revenue?
- What is the all time high annual revenue for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals annual revenue year-on-year change?
- What is ACADIA Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals quarterly revenue year-on-year change?
- What is ACADIA Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals TTM revenue year-on-year change?
What is ACADIA Pharmaceuticals annual revenue?
The current annual revenue of ACAD is $726.44 M
What is the all time high annual revenue for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high annual revenue is $726.44 M
What is ACADIA Pharmaceuticals annual revenue year-on-year change?
Over the past year, ACAD annual revenue has changed by +$209.20 M (+40.45%)
What is ACADIA Pharmaceuticals quarterly revenue?
The current quarterly revenue of ACAD is $250.40 M
What is the all time high quarterly revenue for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high quarterly revenue is $250.40 M
What is ACADIA Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, ACAD quarterly revenue has changed by +$38.70 M (+18.28%)
What is ACADIA Pharmaceuticals TTM revenue?
The current TTM revenue of ACAD is $929.24 M
What is the all time high TTM revenue for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high TTM revenue is $929.24 M
What is ACADIA Pharmaceuticals TTM revenue year-on-year change?
Over the past year, ACAD TTM revenue has changed by +$297.35 M (+47.06%)